WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dario ScimecaGeneral Counsel and Secretary2026-02-184,925$3.84
$18.91kSell
John Alexander KellyChief Financial Officer2026-02-188,149$3.84
$31.29kSell
Michael AmorosoPresident and CEO2026-02-1820,559$3.84
$78.95kSell
J. Jefferson SmithChief Research Officer2026-02-184,925$3.84
$18.91kSell
Michael AmorosoPresident and CEO2026-01-2234,799$4.17
$145.11kSell
J. Jefferson SmithChief Research Officer2026-01-2110,200$4.03
$41.11kSell
Dario ScimecaGeneral Counsel and Secretary2026-01-218,854$4.03
$35.68kSell
John Alexander KellyChief Financial Officer2026-01-2115,213$4.03
$61.31kSell
Geno J. GermanoDirector2025-12-163,000$4.72
$14.16kBuy
Stanley FrankelDirector2025-12-162,700$4.70
$12.69kBuy

1 of 2

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis48.09%12,407,440$95.41MInsider
Venbio Global Strategic Fund LP16.53%4,265,141$32.80MInsider
Derek Jantz15.72%4,055,174$31.18MInsider
Fmr LLC14.49%3,738,248$28.75MInsider
Empery Asset Management LP8.51%2,194,635$16.88MInstitution
Aberdeen Group PLC8.29%2,138,603$16.45MInstitution
Matthew R. Kane7.85%2,024,438$15.57MInsider
Octagon Capital Advisors LP7.43%1,917,995$14.75MInstitution
Bleichroeder LP6.44%1,662,500$12.78MInstitution
Boothbay Fund Management LLC4.13%1,066,050$8.20MInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL35.28%64.72%Net SellingNet Selling
QSI30.98%48.37%Net BuyingNet Buying
SLGL24.11%75.89%Net BuyingNet Buying
UNCY32.27%18.13%
WHWK45.04%54.96%Net SellingNet Selling
View Top Biotech Stocks

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 58.55% institutional shareholders, 107.39% Precision Biosciences insiders, and 0.00% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 48.09% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $95.41M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.